Antônio Jose Inda-Filho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Antônio Jose Inda-Filho has a total of 93 co-authors. Here are the top co-authors by number of shared publications:
- Heitor Siqueira Ribeiro
Faculty of Health Sciences, University of Brasilia, Brasilia, Brazil
9 shared publications - Marvery Peterson Duarte
Faculty of Health Sciences, University of Brasilia, Brasilia, Brazil
7 shared publications - Ricardo Moreno Lima
University of Brasilia
6 shared publications - Aparecido Pimentel Ferreira
Interdisciplinary Research Department University Center ICESP Brasília Brazil
5 shared publications - Daiana Cristine Bündchen
Department of Physiotherapy, Federal University of Santa Catarina, Araranguá, Brazil
5 shared publications - Dário Rosa Mondini
Universidade de São Paulo image/svg+xml
5 shared publications
Latest Publications
- Open Access
- 9 November 2026
- Published by Elsevier in Journal of Renal Nutrition
Is Exercising During Dialysis Enough? Rethinking Approaches to be Physically Active
- 9 November 2026
- Published by Elsevier in Journal of Renal Nutrition
Open AccessIs Exercising During Dialysis Enough? Rethinking Approaches to be Physically Active
- Open Access
- 21 March 2026
- Published by Elsevier in Journal of Renal Nutrition
- Vol. 36 (4) , 623-630
Severity of Cognitive Dysfunction Associates With Sarcopenia in Patients on Hemodialysis: Findings From the SARC-HD Study
- 21 March 2026
- Published by Elsevier in Journal of Renal Nutrition
- Vol. 36 (4) , 623-630
Open AccessSeverity of Cognitive Dysfunction Associates With Sarcopenia in Patients on Hemodialysis: Findings From the SARC-HD Study
- Open Access
- 18 June 2025
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 37 (1) , 1-7
Polypharmacy and sarcopenia in patients on hemodialysis: results from the SARC-HD study
Background We investigated the association between polypharmacy and sarcopenia in patients on hemodialysis. Methods Cross-sectional data from the SARC-HD study were analyzed. Patients were classified according to the number of prescribed medications as no polypharmacy (0–4), polypharmacy (5–9), and hyperpolypharmacy (≥ 10). Sarcopenia was diagnosed and staged according to the adapted EWGSOP2 consensus. Results 955 patients (48% ≥ 60 years, 61% male) were analyzed. Polypharmacy and hyperpolypharmacy were observed in 50% and 26% of patients, respectively. Patients with hyperpolypharmacy had poorer physical function compared to the no polypharmacy group. Low muscle strength was found in 45%, while sarcopenia (confirmed and severe stages) in 21% of the cohort. Patients in the polypharmacy groups had higher prevalence of low muscle strength, but similar sarcopenia rates to those in the no polypharmacy group. Only hyperpolypharmacy was independently associated with low muscle strength (64% higher adjusted odds, 95% CI 1.10–2.46), whereas no significant associations were observed with sarcopenia. Also, each addition of two medications was independently associated with 10% higher adjusted odds (95% CI 1.02–1.20) of low muscle strength. Conclusions In patients on hemodialysis, the number of medications and hyperpolypharmacy were independently associated with low muscle strength, but not with sarcopenia per se.
- 18 June 2025
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 37 (1) , 1-7
Open AccessPolypharmacy and sarcopenia in patients on hemodialysis: results from the SARC-HD study
Background We investigated the association between polypharmacy and sarcopenia in patients on hemodialysis. Methods Cross-sectional data from the SARC-HD study were analyzed. Patients were classified according to the number of prescribed medications as no polypharmacy (0–4), polypharmacy (5–9), and hyperpolypharmacy (≥ 10). Sarcopenia was diagnosed and staged according to the adapted EWGSOP2 consensus. Results 955 patients (48% ≥ 60 years, 61% male) were analyzed. Polypharmacy and hyperpolypharmacy were observed in 50% and 26% of patients, respectively. Patients with hyperpolypharmacy had poorer physical function compared to the no polypharmacy group. Low muscle strength was found in 45%, while sarcopenia (confirmed and severe stages) in 21% of the cohort. Patients in the polypharmacy groups had higher prevalence of low muscle strength, but similar sarcopenia rates to those in the no polypharmacy group. Only hyperpolypharmacy was independently associated with low muscle strength (64% higher adjusted odds, 95% CI 1.10–2.46), whereas no significant associations were observed with sarcopenia. Also, each addition of two medications was independently associated with 10% higher adjusted odds (95% CI 1.02–1.20) of low muscle strength. Conclusions In patients on hemodialysis, the number of medications and hyperpolypharmacy were independently associated with low muscle strength, but not with sarcopenia per se.
- 16 October 2024
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 40 (5) , 987-996
Reference values for handgrip strength, five times sit-to-stand and gait speed in patients on hemodialysis
Low levels of muscle strength and function predict adverse clinical outcomes in patients on hemodialysis; however, reference values remain lacking. We described reference values for handgrip strength, five times sit-to-stand (STS-5), and 4-m gait speed in a large-scale sample in patients on hemodialysis. Baseline data from the SARCopenia trajectories and associations with adverse clinical outcomes in patients on HemoDialysis (SARC-HD) study were analyzed. Muscle strength was evaluated using handgrip strength and the STS-5, whereas physical performance was evaluated using usual 4-m gait speed before a midweek dialysis session. Sex- and age-specific smoothed reference curves for each test at the 3rd, 15th, 50th, 85th, and 97th percentiles were constructed using generalized additive models for location shape and scale. Comparisons between sex and age were also performed. Data from 1004 patients (39% female; 19 to 96 years; 49% ≥ 60 years) were analyzed. Declines in muscle strength and physical performance were observed with advancing age in both sexes. However, among males, muscle strength and performance were similar between 18 and 49 years of age. Males exhibited substantially greater performance in handgrip strength (10.3 kg, 95% confidence interval (CI) 9.1 to 11.4) and 4-m gait speed (–0.10 seconds, 95% CI: –0.14 to –0.05) compared to females. Older patients, independent of sex, exhibited poorer performance on most tests. Lower handgrip strength in the arm with arteriovenous fistula was observed in both sexes (males –2.3 kg, 95% CI: –2.8 to –1.7; and females –2.1 kg, 95% CI: –2.6 to –1.6). Reference values obtained in this study may be used in clinical and research settings to identify patients on hemodialysis with low physical function according to sex and age. Future studies should test these reference values as potential predictors of adverse clinical outcomes.
- 16 October 2024
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 40 (5) , 987-996
Reference values for handgrip strength, five times sit-to-stand and gait speed in patients on hemodialysis
Low levels of muscle strength and function predict adverse clinical outcomes in patients on hemodialysis; however, reference values remain lacking. We described reference values for handgrip strength, five times sit-to-stand (STS-5), and 4-m gait speed in a large-scale sample in patients on hemodialysis. Baseline data from the SARCopenia trajectories and associations with adverse clinical outcomes in patients on HemoDialysis (SARC-HD) study were analyzed. Muscle strength was evaluated using handgrip strength and the STS-5, whereas physical performance was evaluated using usual 4-m gait speed before a midweek dialysis session. Sex- and age-specific smoothed reference curves for each test at the 3rd, 15th, 50th, 85th, and 97th percentiles were constructed using generalized additive models for location shape and scale. Comparisons between sex and age were also performed. Data from 1004 patients (39% female; 19 to 96 years; 49% ≥ 60 years) were analyzed. Declines in muscle strength and physical performance were observed with advancing age in both sexes. However, among males, muscle strength and performance were similar between 18 and 49 years of age. Males exhibited substantially greater performance in handgrip strength (10.3 kg, 95% confidence interval (CI) 9.1 to 11.4) and 4-m gait speed (–0.10 seconds, 95% CI: –0.14 to –0.05) compared to females. Older patients, independent of sex, exhibited poorer performance on most tests. Lower handgrip strength in the arm with arteriovenous fistula was observed in both sexes (males –2.3 kg, 95% CI: –2.8 to –1.7; and females –2.1 kg, 95% CI: –2.6 to –1.6). Reference values obtained in this study may be used in clinical and research settings to identify patients on hemodialysis with low physical function according to sex and age. Future studies should test these reference values as potential predictors of adverse clinical outcomes.
- 15 October 2024
- Published by Wiley in Nutrition in Clinical Practice
- Vol. 39 (6) , 1441-1451
Agreement between the EWGSOP2 and SDOC consensuses for sarcopenia in patients receiving hemodialysis: Findings of a cross sectional analysis from the SARC‐HD study
Background: Differences in definitions and operational diagnoses for sarcopenia create difficulties in understanding the epidemiology of the disease. We examined the prevalences of sarcopenia using the revised European Working Group on Sarcopenia in Older People (EWGSOP2) and the Sarcopenia Definitions and Outcomes Consortium (SDOC) consensuses and analyzed their level of agreement in patients receiving hemodialysis.Methods: Data from the SARCopenia trajectories and associations with clinical outcomes in patients receiving hemodialysis (SARC‐HD) multicenter study in Brazil were analyzed. Muscle strength was assessed using handgrip strength, muscle mass by calf circumference, and physical performance by the 4‐m gait speed test. Sarcopenia was diagnosed according to both the EWGSOP2 (low muscle strength plus low muscle mass) and the SDOC (low muscle strength plus low physical performance). The Cohen kappa statistic was used to determine the level of agreement between the consensuses.Results: 838 patients (57.8 ± 15.0 years; 61% men) from 19 dialysis units were included. We found similar prevalences of sarcopenia between the consensuses (EWGSOP2, n = 128, 15.3%; SDOC, n = 105, 12.5%) but with weak agreement (50 of 233 patients, 21.5%; κ = 0.34, 95% CI 0.25–0.43). Agreement was also weak within age categories (≥60 years, κ = 0.34; P < 0.001). Of the 51 patients diagnosed by the EWGSOP2 criterion as having severe sarcopenia, all but 1 (98.0%) met the SDOC criterion for sarcopenia (κ = 0.61, 95% CI 0.52–0.70). Low muscle strength was more frequently diagnosed using the SDOC than with the EWGSOP2 (52.3% vs 25.9%).Conclusion: We found a weak agreement between the EWGSOP2 and SDOC consensuses for the diagnosis of sarcopenia in patients receiving hemodialysis. Although still weak, agreement was marginally better for older patients. These findings highlight the importance of a global and standardized conceptual diagnosis of sarcopenia.
- 15 October 2024
- Published by Wiley in Nutrition in Clinical Practice
- Vol. 39 (6) , 1441-1451
Agreement between the EWGSOP2 and SDOC consensuses for sarcopenia in patients receiving hemodialysis: Findings of a cross sectional analysis from the SARC‐HD study
Background: Differences in definitions and operational diagnoses for sarcopenia create difficulties in understanding the epidemiology of the disease. We examined the prevalences of sarcopenia using the revised European Working Group on Sarcopenia in Older People (EWGSOP2) and the Sarcopenia Definitions and Outcomes Consortium (SDOC) consensuses and analyzed their level of agreement in patients receiving hemodialysis.Methods: Data from the SARCopenia trajectories and associations with clinical outcomes in patients receiving hemodialysis (SARC‐HD) multicenter study in Brazil were analyzed. Muscle strength was assessed using handgrip strength, muscle mass by calf circumference, and physical performance by the 4‐m gait speed test. Sarcopenia was diagnosed according to both the EWGSOP2 (low muscle strength plus low muscle mass) and the SDOC (low muscle strength plus low physical performance). The Cohen kappa statistic was used to determine the level of agreement between the consensuses.Results: 838 patients (57.8 ± 15.0 years; 61% men) from 19 dialysis units were included. We found similar prevalences of sarcopenia between the consensuses (EWGSOP2, n = 128, 15.3%; SDOC, n = 105, 12.5%) but with weak agreement (50 of 233 patients, 21.5%; κ = 0.34, 95% CI 0.25–0.43). Agreement was also weak within age categories (≥60 years, κ = 0.34; P < 0.001). Of the 51 patients diagnosed by the EWGSOP2 criterion as having severe sarcopenia, all but 1 (98.0%) met the SDOC criterion for sarcopenia (κ = 0.61, 95% CI 0.52–0.70). Low muscle strength was more frequently diagnosed using the SDOC than with the EWGSOP2 (52.3% vs 25.9%).Conclusion: We found a weak agreement between the EWGSOP2 and SDOC consensuses for the diagnosis of sarcopenia in patients receiving hemodialysis. Although still weak, agreement was marginally better for older patients. These findings highlight the importance of a global and standardized conceptual diagnosis of sarcopenia.
- 8 May 2022
- Published by Wiley in Journal of Renal Care
- Vol. 49 (2) , 125-133
Implementing a resistance training programme for patients on short daily haemodialysis: A feasibility study
Background: Kidney failure patients receiving haemodialysis experience protein‐energy wasting, muscle mass loss and physical function impairment. Intradialytic exercise interventions seem to modify these features, but they are often not implemented as a clinical routine.Objective: To investigate the feasibility of implementing a supervised intradialytic resistance training programme as a clinical routine for patients receiving short daily haemodialysis.Design: A prospective longitudinal study.Participants: Eighteen patients in a supervised intradialytic resistance training programme for 8 months.Measurements: It consisted of a warm‐up, lower‐ and upper‐limb resistance exercises and a cool‐down. Patients performed the resistance training during the first half of haemodialysis, twice a week, supervised by exercise physiologists and physiotherapists. The feasibility was assessed by the total and partial adherences, the reasons for refusing or for not exercising and the intradialytic complications.Results: From a total of 953 potential exercise sessions, 759 were performed, with a 79.6% adherence rate. In the first 9 weeks, the adherence rate was 86.6% and the lowest rate was in the 19–27 weeks (73.5%). The main intradialytic complication during exercise sessions was hypotension (n = 31; 4.1%). The highest number of complications was reported during the first 9 weeks (n = 27; 9.1%). The main reasons for refusing or for not performing the intradialytic exercise sessions were clinical complications previous to exercise time (n = 63; 32.5%) and self‐reported indisposition (n = 62; 32.0%).Conclusions: The intradialytic resistance training programme, supervised by exercise physiologists and physiotherapists, had very low complications, achieved a high long‐term adherence rate and showed to be feasible as a clinical routine for patients receiving short daily haemodialysis.
- 8 May 2022
- Published by Wiley in Journal of Renal Care
- Vol. 49 (2) , 125-133
Implementing a resistance training programme for patients on short daily haemodialysis: A feasibility study
Background: Kidney failure patients receiving haemodialysis experience protein‐energy wasting, muscle mass loss and physical function impairment. Intradialytic exercise interventions seem to modify these features, but they are often not implemented as a clinical routine.Objective: To investigate the feasibility of implementing a supervised intradialytic resistance training programme as a clinical routine for patients receiving short daily haemodialysis.Design: A prospective longitudinal study.Participants: Eighteen patients in a supervised intradialytic resistance training programme for 8 months.Measurements: It consisted of a warm‐up, lower‐ and upper‐limb resistance exercises and a cool‐down. Patients performed the resistance training during the first half of haemodialysis, twice a week, supervised by exercise physiologists and physiotherapists. The feasibility was assessed by the total and partial adherences, the reasons for refusing or for not exercising and the intradialytic complications.Results: From a total of 953 potential exercise sessions, 759 were performed, with a 79.6% adherence rate. In the first 9 weeks, the adherence rate was 86.6% and the lowest rate was in the 19–27 weeks (73.5%). The main intradialytic complication during exercise sessions was hypotension (n = 31; 4.1%). The highest number of complications was reported during the first 9 weeks (n = 27; 9.1%). The main reasons for refusing or for not performing the intradialytic exercise sessions were clinical complications previous to exercise time (n = 63; 32.5%) and self‐reported indisposition (n = 62; 32.0%).Conclusions: The intradialytic resistance training programme, supervised by exercise physiologists and physiotherapists, had very low complications, achieved a high long‐term adherence rate and showed to be feasible as a clinical routine for patients receiving short daily haemodialysis.
- 7 January 2022
- Published by Wiley in Nutrition in Clinical Practice
- Vol. 37 (6) , 1356-1365
SARC‐F and SARC‐CalF are associated with sarcopenia traits in hemodialysis patients
Background: The SARC‐F questionnaire assesses sarcopenia risk. The addition of a calf circumference measurement, known as SARC‐CalF, has been recently proposed. We investigated possible associations of SARC‐F and SARC‐CalF with sarcopenia traits in patients undergoing hemodialysis.Methods: Thirty patients (17 men; 57 ± 15 years) were enrolled. Sarcopenia risk was assessed by SARC‐F (≥4) and SARC‐CalF (≥11). Probable (low muscle strength or low skeletal muscle mass [SMM]) and confirmed (both) sarcopenia were diagnosed as recommended by the revised European Working Group on Sarcopenia in Older People. Muscle strength was assessed by handgrip strength (HGS) and five‐time sit‐to‐stand test (STS‐5), and physical performance was evaluated by gait speed. SMM was assessed by bioelectrical impedance.Results: Sarcopenia risk by the SARC‐F and SARC‐CalF were found in 23% (n = 7) and 40% (n = 12) patients, respectively. The SARC‐F and SARC‐CalF were both associated with physical function, but not with SMM. Probable sarcopenia by HGS was associated with SARC‐F and SARC‐CalF. Moreover, both showed moderate Kappa agreement with slowness and probable sarcopenia by HGS and/or STS‐5, but only SARC‐CalF with probable sarcopenia by HGS. A larger sensitivity was found for SARC‐CalF than SARC‐F in detecting probable sarcopenia by HGS (70% vs 30%) and by HGS and/or STS‐5 (63% vs 44%).Conclusion: SARC‐F and SARC‐CalF are associated with sarcopenia traits in patients undergoing hemodialysis. SARC‐CalF seems to be more strongly associated with sarcopenia traits and present a higher sensitivity for probable sarcopenia than SARC‐F, as it adds a direct measurement.
- 7 January 2022
- Published by Wiley in Nutrition in Clinical Practice
- Vol. 37 (6) , 1356-1365
SARC‐F and SARC‐CalF are associated with sarcopenia traits in hemodialysis patients
Background: The SARC‐F questionnaire assesses sarcopenia risk. The addition of a calf circumference measurement, known as SARC‐CalF, has been recently proposed. We investigated possible associations of SARC‐F and SARC‐CalF with sarcopenia traits in patients undergoing hemodialysis.Methods: Thirty patients (17 men; 57 ± 15 years) were enrolled. Sarcopenia risk was assessed by SARC‐F (≥4) and SARC‐CalF (≥11). Probable (low muscle strength or low skeletal muscle mass [SMM]) and confirmed (both) sarcopenia were diagnosed as recommended by the revised European Working Group on Sarcopenia in Older People. Muscle strength was assessed by handgrip strength (HGS) and five‐time sit‐to‐stand test (STS‐5), and physical performance was evaluated by gait speed. SMM was assessed by bioelectrical impedance.Results: Sarcopenia risk by the SARC‐F and SARC‐CalF were found in 23% (n = 7) and 40% (n = 12) patients, respectively. The SARC‐F and SARC‐CalF were both associated with physical function, but not with SMM. Probable sarcopenia by HGS was associated with SARC‐F and SARC‐CalF. Moreover, both showed moderate Kappa agreement with slowness and probable sarcopenia by HGS and/or STS‐5, but only SARC‐CalF with probable sarcopenia by HGS. A larger sensitivity was found for SARC‐CalF than SARC‐F in detecting probable sarcopenia by HGS (70% vs 30%) and by HGS and/or STS‐5 (63% vs 44%).Conclusion: SARC‐F and SARC‐CalF are associated with sarcopenia traits in patients undergoing hemodialysis. SARC‐CalF seems to be more strongly associated with sarcopenia traits and present a higher sensitivity for probable sarcopenia than SARC‐F, as it adds a direct measurement.
- 23 December 2021
- Published by Wiley in Therapeutic Apheresis and Dialysis
- Vol. 26 (5) , 924-931
Physical activity is associated with nutritional biomarkers in hemodialysis patients: A cross‐sectional study
Objective To explore the association between physical activity levels with nutritional biomarkers in hemodialysis patients. Methods Eighty-six patients response the short version of the International Physical Activity Questionnaire to identify the physical activity levels and estimate the metabolic equivalent of tasks per week. The nutritional biomarkers were also collected. Findings Sixty-five patients (75.6%) were considered sedentary. Binary logistic regression analysis showed that patients with low albumin levels had an 89% lower chance to be physically active (p=0.037), but it was not significant in the adjusted analysis (p=0.052). Albumin and albumin/globulin ratio levels was associated with MET-min per week (all P<0.05). Additionally, lower median albumin and albumin/globulin ratio levels were found in the sedentary patients (p = 0.021 and p=0.031), respectively. Conclusion The physical activity levels were associated with albumin and albumin/globulin ratio, surrogates of nutritional status in hemodialysis patients. These nutritional biomarkers were lower in sedentary patients.
- 23 December 2021
- Published by Wiley in Therapeutic Apheresis and Dialysis
- Vol. 26 (5) , 924-931
Physical activity is associated with nutritional biomarkers in hemodialysis patients: A cross‐sectional study
Objective To explore the association between physical activity levels with nutritional biomarkers in hemodialysis patients. Methods Eighty-six patients response the short version of the International Physical Activity Questionnaire to identify the physical activity levels and estimate the metabolic equivalent of tasks per week. The nutritional biomarkers were also collected. Findings Sixty-five patients (75.6%) were considered sedentary. Binary logistic regression analysis showed that patients with low albumin levels had an 89% lower chance to be physically active (p=0.037), but it was not significant in the adjusted analysis (p=0.052). Albumin and albumin/globulin ratio levels was associated with MET-min per week (all P<0.05). Additionally, lower median albumin and albumin/globulin ratio levels were found in the sedentary patients (p = 0.021 and p=0.031), respectively. Conclusion The physical activity levels were associated with albumin and albumin/globulin ratio, surrogates of nutritional status in hemodialysis patients. These nutritional biomarkers were lower in sedentary patients.
- Open Access
- 1 December 2021
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 43 (4) , 580-585
Epidemiological profile of acute kidney injury in critically ill patients admitted to intensive care units: A Prospective Brazilian Cohort
Introduction Acute kidney injury (AKI) is a frequent syndrome affecting patients admitted to intensive care units (ICU), and it is associated with poor clinical outcomes. The aim of the present study was to understand the epidemiological profile of patients with AKI admitted to ICUs. Methods Prospective cohort study, carried out in three ICUs in the Federal District, Brazil. Between October/2017 and December/2018, 8,131 patients were included in the cohort. AKI was defined according to the KDIGO criteria. The main outcomes assessed were AKI development and mortality within 28 days of hospitalization. Results Of the 8,131 patients followed up, 1,728 developed AKI (21.3%). Of the 1,728 patients with AKI, 1,060 (61.3%) developed stage 1, while stages 2 and 3 represented 154 (8.9%) and 514 (29.7%), respectively. Of these, 459 (26.6%) underwent renal replacement therapy. The mortality was 25.7% for those with AKI, and 4.9% for those without AKI. Discussion Patients with AKI had higher mortality rates when compared to those without AKI. Likewise, among patients with AKI, higher disease stages were associated with higher death occurrences. AKI incidence (21.3%) and mortality (25.7%) in our study is in line with the largest meta-analysis ever conducted, in which incidence and mortality of 21.6 and 23.9% were observed, respectively. These findings confirm the importance of establishing the KDIGO guideline for the definition and management of AKI in Brazilian ICUs.
- 1 December 2021
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 43 (4) , 580-585
Open AccessEpidemiological profile of acute kidney injury in critically ill patients admitted to intensive care units: A Prospective Brazilian Cohort
Introduction Acute kidney injury (AKI) is a frequent syndrome affecting patients admitted to intensive care units (ICU), and it is associated with poor clinical outcomes. The aim of the present study was to understand the epidemiological profile of patients with AKI admitted to ICUs. Methods Prospective cohort study, carried out in three ICUs in the Federal District, Brazil. Between October/2017 and December/2018, 8,131 patients were included in the cohort. AKI was defined according to the KDIGO criteria. The main outcomes assessed were AKI development and mortality within 28 days of hospitalization. Results Of the 8,131 patients followed up, 1,728 developed AKI (21.3%). Of the 1,728 patients with AKI, 1,060 (61.3%) developed stage 1, while stages 2 and 3 represented 154 (8.9%) and 514 (29.7%), respectively. Of these, 459 (26.6%) underwent renal replacement therapy. The mortality was 25.7% for those with AKI, and 4.9% for those without AKI. Discussion Patients with AKI had higher mortality rates when compared to those without AKI. Likewise, among patients with AKI, higher disease stages were associated with higher death occurrences. AKI incidence (21.3%) and mortality (25.7%) in our study is in line with the largest meta-analysis ever conducted, in which incidence and mortality of 21.6 and 23.9% were observed, respectively. These findings confirm the importance of establishing the KDIGO guideline for the definition and management of AKI in Brazilian ICUs.